Statins in Non-alcoholic Steatohepatitis
Non-alcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease. The range is extensive, including hepatocellular carcinoma, cirrhosis, fibrosis, fatty liver, and non-alcoholic steatohepatitis (NASH). NASH is a condition related to obesity, overweight, metabolic syndrome, dia...
Guardado en:
Autores principales: | Jose D. Torres-Peña, Laura Martín-Piedra, Francisco Fuentes-Jiménez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d2e4d270a49241b4bc559e2a4a558e61 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statin Therapy in Very Old Patients: Lights and Shadows
por: Lidia Cobos-Palacios, et al.
Publicado: (2021) -
Cerebrovascular Disease and Statins
por: Luis M. Beltrán Romero, et al.
Publicado: (2021) -
Statins and Peripheral Arterial Disease: A Narrative Review
por: Sergio Jansen-Chaparro, et al.
Publicado: (2021) -
Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
por: John N. Booth, et al.
Publicado: (2018) -
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
por: Michael G. Nanna, et al.
Publicado: (2018)